ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 671,34
1,34%
Dow Jones
39 134,76
0,77%
DAX
18 254,18
1,03%
Brent Oil
84,925
-0,09%
Bitcoin
64 758,84
-0,10%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Vericel Corporation (VCEL)

  7. Vericel Corporation (VCEL) Actualités

VCEL Vericel Corporation

44,66
1,29 (2,97%)
20 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Vericel Corporation VCEL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
1,29 2,97% 44,66 23:57:56
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
44,12 43,57 45,83 44,66 43,37
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
14/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202422:13EDGAR2Form 144 - Report of proposed sale of securities
12/6/202422:18EDGAR2Form 144 - Report of proposed sale of securities
11/6/202414:30GLOBEVericel to Present at the Truist Securities MedTech..
05/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202414:30GLOBEVericel to Present at the Leerink Partners Healthcare..
21/5/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202418:15EDGAR2Form 144 - Report of proposed sale of securities
17/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202416:43EDGAR2Form 144 - Report of proposed sale of securities
15/5/202419:10EDGAR2Form 144 - Report of proposed sale of securities
08/5/202414:59EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202414:10EDGAR2Form 8-K - Current report
08/5/202413:55GLOBEVericel Reports First Quarter 2024 Financial Results and..
24/4/202414:30GLOBEVericel to Report First-Quarter 2024 Financial Results on..
11/3/202421:15EDGAR2Form 144 - Report of proposed sale of securities
11/3/202421:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202421:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:12EDGAR2Form 144 - Report of proposed sale of securities
07/3/202421:35EDGAR2Form 144 - Report of proposed sale of securities
29/2/202415:04EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202414:04EDGAR2Form 8-K - Current report
29/2/202413:55GLOBEVericel Reports Fourth Quarter and Full-Year 2023 Financial..
27/2/202414:30GLOBEVericel to Present at the TD Cowen 44th Annual Health Care..
26/2/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:23EDGAR2Form 144 - Report of proposed sale of securities
16/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:22EDGAR2Form 144 - Report of proposed sale of securities
15/2/202414:30GLOBEVericel to Report Fourth-Quarter and Full-Year 2023..
14/2/202422:15EDGAR2Form 144 - Report of proposed sale of securities
14/2/202413:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202412:01EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
05/2/202414:30GLOBEVericel to Present at the Canaccord Genuity Musculoskeletal..
30/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202422:17EDGAR2Form 144 - Report of proposed sale of securities
29/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:27EDGAR2Form 144 - Report of proposed sale of securities

Dernières Valeurs Consultées

NASDAQ
VCEL
Vericel
BIT
PEX
Exchange Traded Fund Ubs...
LSE
61SG
Mitsu Hc Cap 29
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés